• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Healthcare

Adelis exits Nordentic to PE-backed Corus

  • Rachel Lewis
  • 31 August 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Adelis Equity Partners has sold its majority stake in Nordic dental labs group Nordentic to peer Corus, backed by CareVentures and Quadrum Capital.

The acquisition takes Corus, which offers dental lab products and services, into the Nordics from a network across France, Iberia, and the Benelux countries. 

The transaction is expected to close in Q3 of 2022. 

Corus aims to have a revenue of EUR 180m by the end of 2022, following the integration with Nordentic and consolidation of other laboratories, the company said in a statement. 

Spain-based CareVentures, the major stakeholder, has been working with Lincoln International to secure refinancing for the growth strategy, as first reported by Unquote's sister publication Debtwire. 

The refi structures Corus off EUR 20m-EUR 25m in EBITDA, and could provide an acquisition line in the region of EUR 40m-EUR 50m, as reported. 

CareVentures first formed the asset in 2015, while Quantum Capital joined as a minority shareholder in March this year when its portco Signadens, a Dutch peer with EUR 25m sales, merged with Corus.  

After the Nordentic acquisition, the group will operate through 63 laboratories and more than 1,500 employees. 

Adelis first acquired Nordentic via its maiden fund, Adelis Equity Partners Fund I, in May 2017 for EUR 30m, according to Unquote data. Nordentic management and lab directors will become shareholders in Corus. 

The GP said that Nordentic had grown to 20 dental labs over the course of its tenure. 

The exit is the second in a week for Fund I, as the 2012 vintage fund reaches the end of its lifespan. Adelis earlier raised a continuation vehicle for its tropical disease diagnostics company SSI Diagnostica. 

Other unrealised assets include Christmas tree grower Green Tree Group, sporting goods chain Intersport, and digital marketing agency Genaraxion (formerly known as Sogemedier).

Advisors

Adelis - Clearwater International (M&A); White & Case (legal) and Svalner (tax).

 

 

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Healthcare
  • Exits
  • Buyouts
  • GPs
  • Adelis Equity Partners

More on Healthcare

Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global

Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt

  • Healthcare
  • 26 May 2023
Forbion raises combined EUR 1.35bn for venture and growth funds
Forbion raises combined EUR 1.35bn for venture and growth funds

Ventures Fund VI closes on EUR 750m and Growth Opportunities II on EUR 600m with both upsized by over 60%

  • Healthcare
  • 19 April 2023
EQT closes LSP Dementia on EUR 260m hard cap
EQT closes LSP Dementia on EUR 260m hard cap

Series A-focused fund exceeded its EUR 100m target and extended fundraising after increased LP interest in its strategy

  • Healthcare
  • 30 March 2023
Ardian reinvests in Neopharmed alongside NB Renaissance
Ardian reinvests in Neopharmed alongside NB Renaissance

French GP will move stake from fund VI to VII; additional capital allows for European M&A

  • Healthcare
  • 10 November 2022

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013